Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals
- Author:
Myung Hee KIM
1
;
Duk Ki KIM
;
Hyuk Soo EUN
;
Woo Sun ROU
;
Seok Hyun KIM
;
Byung Seok LEE
Author Information
- Publication Type:Case Report
- Keywords: Hydrothorax; Liver cirrhosis; Hepacivirus; Pleural effusion
- MeSH: Antiviral Agents; Diuretics; Female; Fibrosis; Hepacivirus; Hepatitis C, Chronic; Hepatitis, Chronic; Humans; Hydrothorax; Incidence; Liver; Liver Cirrhosis; Liver Transplantation; Middle Aged; Pleural Effusion; Portasystemic Shunt, Surgical
- From:The Korean Journal of Gastroenterology 2020;75(2):98-102
- CountryRepublic of Korea
- Language:English
- Abstract: Hepatic hydrothorax is a transudative pleural effusion that complicates advanced liver cirrhosis. Patients refractory to medical treatment plus salt restriction and diuretics are considered to have refractory hepatic hydrothorax and may require transjugular intrahepatic portosystemic shunt (TIPS) or liver transplant. Successful antiviral therapy reduces the incidence of some complications of cirrhosis secondary to HCV infection. We report a case of hepatic hydrothorax in a 55-year-old female patient with HCV cirrhosis, which exhibited a spontaneous decrease in pleural effusion after direct antiviral agent (DAA) therapy. In cases of HCV cirrhosis, DAAs are worth administering before treatment by TIPS or liver transplantation.
